Besides, many studies also showed that overexpression of NUSAP1 was associated with poor survival of colon cancer (Liu et al., 2018), astrocytoma (Wu et al., 2017), glioblastoma multiforme (Qian et al., 2018), renal cell carcinoma (Fang et al., 2016), prostate cancer (Gordon et al., 2017), breast cancer (Chen et al., 2015), and esophageal squamous cell carcinoma (Guan et al., 2019). Here, NUSAP1 is linked to malignant colon neoplasm.